With all due respect CP…….
I am perplexed as to why you fail to understand how long-term shareholders find the following insulting:
Last year management stated….
Quote:
________________________________________
We expect that with the additional 8,000,000 shares for which we are seeking stockholder approval, we will have sufficient shares for our equity compensation program for at least two or more fiscal years
________________________________________
And now they have the audacity to come back the very next year and request an additional 7M shares.
Can you reconcile why this should be acceptable to the retail shareholders given the ROI afforded by this regime?
As it stands today, the deplorable share price and obnoxious outstanding share count are the direct result of a squad that has been extremely poor stewards of company resources. Period.
The adversarial relationship between themselves and many retail shareholders is all their making and wouldn’t have been all that difficult to avoid.
Over the past….ooooh…half decade or so, management could have sent a message that we are all in this together by reaching into A$$ international, and making a serious market purchase of shares outside of the granted options. Except for Swartz, they refused to and it says “a lot” regarding how these guys roll.
Many here argue that “we don’t want to give the platform away for pennies on the dollar”…in a round- about way, they sort of already have with the massive dilution at these arm-pit share prices. If a partnership was really close to being finalized, that probably wouldn’t have been necessary. As it stands, it doesn’t appear Steve’s go it alone bluff is panning out. Cup a hand to your ear and point it towards Wall Street…they are booing PPHM.
The share price, shareholders and PPHM are collectively suffering from an acute case of Stephen King’s “a boy who cried wolf syndrome”. The final crutch just got kicked out from under management when the frivolous lawsuit was dismissed. Time to produce….yesterday…not some hopeful day after management wastes more time attempting to extract every n’th dime from a potential partner. We are wasting time, Cotara is sadly rotting on the shelve when it should have been well into enrolling.
The undue misery that this management team has wrought on the long term shareholders is simply inexcusable. The second line lung cancer results sell themselves, and yet King, as of today, hasn’t been able to capitalize.
In my opinion, Bavi A/C should have been partnered after the Georgia and India Lung and Breast cancer results even though some say the results were questionable based on cherry picking the patients.
I believe the platform would have been way further along in other indications, we would have better control over R84, outstanding shares would be materially less than where we are now and the share price, who knows how high had one of the countless offers been accepted.
King and company are too “comfortable” with their gig, don’t feel enough pressure to deliver and have failed to provide a reasonable return on investment given our current situation.
Take a look at the stock chart under Kings tenure. The technical chart description is rightfully branded “man urinating off a cliff chart formation”….not exactly one of the more sought after ones to be invested in….and given the incredible success of second line lung, makes little sense. The current report card for this regime is the share price….like it or not. The constant whistling the theme song to the musical Annie by many here just isn’t cutting it any more.
Maybe everything changes in the next 30 or so days with some expected good news. I welcome it and somewhat expect it. I would suggest that King drop all remaining ordinance as it relates to positive pr’s coming into this upcoming vote….I believe he is plum out of shareholder goodwill and shouldn’t take the upcoming vote foregranted. I’ll withhold my vote until the last minute, but if everything remains as is, voting against management will be the easiest decision I make all year.
Show me the money….not too difficult to understand.
…Awesome research Eyebuy on BTD, very impressive.
All IMHO
